Significance of Skin Barrier Dysfunction in Atopic Dermatitis
نویسندگان
چکیده
Atopic dermatitis (AD) is the most common chronic skin disease worldwide. It affects about 20% of children and 5% of adults. Patients with persistent or severe AD suffer from profound impairment of their quality of life. Additionally, AD places a heavy economic burden on patients and their family. AD is strongly associated with the development of food allergy, bronchial asthma, and allergic rhinitis, commonly referred to as the Atopic March. The epidermis provides a physical and functional barrier to the human body, and skin barrier defects are the most important pathologic findings in AD skin. Skin barrier defects have been considered an initial step in developing AD. Recently, investigators have demonstrated that multiple factors, including immune dysregulation, defects in terminal epithelial differentiation such as lack of filaggrin (FLG), deficiency of antimicrobial peptides (AMPs), altered composition of stratum corneum intercellular lipids, and altered skin microbiome may affect skin barrier function (Fig. 1). These factors interact with each other and may modify skin barrier function. In this review, we discuss normal skin barrier and pathogenesis of skin barrier defects associated with the development of AD skin disease. Additionally, we review the role of emollients, anti-inflammatory agents, sodium hypochlorite, probiotics, and microbiome in the treatment and prevention of AD development. Moreover, various types of immune-directed targets for biologic therapy are reviewed. Normal skin barrier The skin barrier plays a critical role in preventing allergen and microbial penetration into the human body. The epidermis consists of a 15to 30-nm-thick layer of proteins and lipids, and provides a physical and functional barrier to the human body. The physical skin barrier is mainly localized to the uppermost area of the epidermis which is the cornified layer (stratum corneum). The epidermis is continuously regenerated by terminally differentiating keratinocytes, which is known as cornification or keratinization. Cornification begins with the migration of keratinocytes from the basal to upper layers, and ends with the formation of the cornified layer. During epidermal differentiation, lipids are produced by keratinocytes and extruded into the extracellular space to form extracellular lipid-enriched layers. Omega-hydroxy-ceramides are covalently bound to cornified envelope proteins and form the backbone for the subsequent addition of free ceramides, free fatty acids, and cholesterol in the cornified layer. The epidermis undergoes complete turnover every 28 days. Cell proliferation, differentiation, and death occur sequentialReview Allergy Asthma Immunol Res. 2018 Forthcoming. Posted online 2018 pISSN 2092-7355 • eISSN 2092-7363
منابع مشابه
Pathogenesis of Atopic Dermatitis: Current Paradigm
Atopic dermatitis (AD) is characterized by skin inflammation, barrier dysfunction and chronic pruritus. In this review, recent advances in the pathogenesis of AD are summarized. Clinical efficacy of the anti-IL-4 receptor antibody dupilumab implies that type 2 cytokines IL-4 and IL-13 have pivotal roles in atopic inflammation. The expression of IL-4 and IL-13 as well as type 2 chemokines such a...
متن کاملAssociation of LL-37 and IL-31 serum levels with SCORing Atopic Dermatitis (SCORAD) score in atopic dermatitis patients
Background: Atopic dermatitis is a chronic, recurrent inflammation of the skin, accompanied by severe pruritus. Immune system dysregulation and skin barrier defects are associated with the abnormalities in atopic dermatitis. Myriad pieces of evidence have pointed to the major roles of LL-37 and interleukin-31 (IL31)in atopic dermatitis. The studies on atopic dermatitis are still limited i...
متن کاملBarrier-Restoring Therapies in Atopic Dermatitis: Current Approaches and Future Perspectives
Atopic dermatitis is a multifactorial, chronic relapsing, inflammatory disease, characterized by xerosis, eczematous lesions, and pruritus. The latter usually leads to an "itch-scratch" cycle that may compromise the epidermal barrier. Skin barrier abnormalities in atopic dermatitis may result from mutations in the gene encoding for filaggrin, which plays an important role in the formation of co...
متن کاملBiology of Human Tumors Skin Barrier Dysfunction and Low Antimicrobial Peptide Expression in Cutaneous T-cell Lymphoma
Purpose:Atopic dermatitis is characterizedbydecreased expressionof filaggrin and loricrin. Patientswith atopic dermatitis often suffer from skin infections, which are also frequently seen in patients with cutaneous T-cell lymphoma (CTCL). In this study, we aimed to investigate the skin barrier in CTCL. Experimental Design:We assessed skinmoisture and transepidermal water loss (TEWL) in patients...
متن کاملClinical use of a ceramide-based moisturizer for treating dogs with atopic dermatitis
In humans, skin barrier dysfunction is thought to be responsible for enhanced penetration of allergens. Similar to conditions seen in humans, canine atopic dermatitis (CAD) is characterized by derangement of corneocytes and disorganization of intercellular lipids in the stratum corenum (SC) with decreased ceramide levels. This study was designed to evaluate the effects of a moisturizer containi...
متن کاملManagement of Patients with Atopic Dermatitis: The Role of Emollient Therapy
Atopic dermatitis is a common inflammatory skin disorder that afflicts a growing number of young children. Genetic, immune, and environmental factors interact in a complex fashion to contribute to disease expression. The compromised stratum corneum found in atopic dermatitis leads to skin barrier dysfunction, which results in aggravation of symptoms by aeroallergens, microbes, and other insults...
متن کامل